Skip to main content

C2 Life Sciences LLC

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists C2 Life Sciences LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

LIANY LianBio

Director, 10% Owner5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 22, 2022 (view filing)9:17 AM ETAug 184 daysEdelman Joseph and 7 othersDirector, 10% OwnerPPurchaseAmerican Depositary Shares+998.2K$2.40+$2.40M+36.6%3.73M after
May 27, 2022 (view filing)10:06 AM ETMay 261 dayEdelman Joseph and 7 othersDirector, 10% OwnerPPurchaseAmerican Depositary Shares+69.0K$3.13+$216.0K+2.6%2.73M after
May 25, 2022 (view filing)6:51 PM ETMay 23-252 daysEdelman Joseph and 7 othersDirector, 10% OwnerPPurchaseAmerican Depositary Shares+171.3K$2.58+$442.4K+6.9%2.66M after3 lots
Nov 5, 2021 (view filing)1:47 PM ETNov 32 daysEdelman Joseph and 7 othersDirector, 10% OwnerPPurchase+2.27M$15.98+$36.3M+8.9%27.9M after2 lots
Nov 3, 2021 (view filing)6:59 PM ETNov 1-22 daysPerceptive Advisors LLC and 7 othersDirector, 10% OwnerPPurchase+220.0K$14.59+$3.21M+3.1%7.25M after2 lots